Entero Healthcare Solutions Limited (NSE: ENTERO)
India
· Delayed Price · Currency is INR 1,320.20
+15.80 (1.21%)
Oct 8, 2024, 3:30 PM IST
ENTERO Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Revenue | 41,322 | 39,223 | 33,002 | 25,221 | 17,731 | 13,496 |
| Revenue Growth (YoY) | 21.22% | 18.85% | 30.85% | 42.24% | 31.38% | - |
| Cost of Revenue | 37,517 | 35,744 | 30,348 | 23,143 | 16,398 | 12,400 |
| Gross Profit | 3,805 | 3,480 | 2,654 | 2,077 | 1,333 | 1,097 |
| Selling, General & Admin | 1,638 | 1,563 | 1,364 | 1,234 | 786.76 | 595.54 |
| Other Operating Expenses | 883.64 | 798.01 | 650.33 | 599.12 | 346.13 | 259.42 |
| Operating Expenses | 2,779 | 2,611 | 2,257 | 2,030 | 1,296 | 969.95 |
| Operating Income | 1,026 | 868.26 | 397.7 | 46.84 | 37.22 | 126.66 |
| Interest Expense | -557.96 | -604.82 | -444 | -260.95 | -163.8 | -116.59 |
| Interest & Investment Income | 133.32 | 133.32 | 40.9 | 34.39 | 29.43 | 28.92 |
| Currency Exchange Gain (Loss) | 0.34 | 0.34 | 0.15 | 1.58 | 3.83 | 1.94 |
| Other Non Operating Income (Expenses) | -41.91 | -41.91 | -31.63 | -19.97 | -15.06 | -11.13 |
| EBT Excluding Unusual Items | 559.63 | 355.19 | -36.88 | -198.11 | -108.38 | 29.81 |
| Gain (Loss) on Sale of Investments | - | - | - | - | - | 10.45 |
| Gain (Loss) on Sale of Assets | 0.36 | 0.36 | - | - | - | - |
| Asset Writedown | - | - | - | - | - | -1.58 |
| Pretax Income | 559.99 | 355.55 | -36.88 | -198.11 | -108.38 | 38.67 |
| Income Tax Expense | 20.99 | -42.44 | 74.16 | 96.28 | 45.16 | 25.81 |
| Earnings From Continuing Operations | 539 | 397.99 | -111.04 | -294.39 | -153.54 | 12.86 |
| Minority Interest in Earnings | -9.51 | -6.9 | -4.53 | -4.81 | -1.83 | -3.42 |
| Net Income | 529.49 | 391.09 | -115.57 | -299.2 | -155.37 | 9.44 |
| Net Income to Common | 529.49 | 391.09 | -115.57 | -299.2 | -155.37 | 9.44 |
| Shares Outstanding (Basic) | 38 | 36 | 4 | 2 | 0 | - |
| Shares Outstanding (Diluted) | 38 | 36 | 4 | 2 | 0 | - |
| Shares Change (YoY) | 12.19% | 779.74% | 163.71% | 1455.99% | - | - |
| EPS (Basic) | 13.77 | 10.81 | -28.11 | -191.91 | -1550.60 | - |
| EPS (Diluted) | 13.76 | 10.81 | -28.11 | -191.91 | -1550.60 | - |
| Free Cash Flow | - | -420.28 | -508.34 | -451.31 | -782.13 | -814.72 |
| Free Cash Flow Per Share | - | -11.62 | -123.64 | -289.47 | -7805.69 | - |
| Gross Margin | 9.21% | 8.87% | 8.04% | 8.24% | 7.52% | 8.13% |
| Operating Margin | 2.48% | 2.21% | 1.21% | 0.19% | 0.21% | 0.94% |
| Profit Margin | 1.28% | 1.00% | -0.35% | -1.19% | -0.88% | 0.07% |
| Free Cash Flow Margin | - | -1.07% | -1.54% | -1.79% | -4.41% | -6.04% |
| EBITDA | 1,106 | 950.02 | 487.22 | 118.84 | 97.75 | 169.37 |
| EBITDA Margin | 2.68% | 2.42% | 1.48% | 0.47% | 0.55% | 1.25% |
| D&A For EBITDA | 79.82 | 81.76 | 89.52 | 72 | 60.53 | 42.71 |
| EBIT | 1,026 | 868.26 | 397.7 | 46.84 | 37.22 | 126.66 |
| EBIT Margin | 2.48% | 2.21% | 1.21% | 0.19% | 0.21% | 0.94% |
| Effective Tax Rate | 3.75% | - | - | - | - | 66.75% |
| Revenue as Reported | 41,466 | 39,367 | 33,057 | 25,265 | 17,837 | 13,543 |
| Advertising Expenses | - | 44.88 | 65.88 | 70.98 | 17.73 | 3.59 |
Source: S&P Capital IQ. Standard template. Financial Sources.